<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Physiology</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Physiology</journal-title><trans-title-group xml:lang="ru"><trans-title>Российский физиологический журнал им. И.М. Сеченова</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0869-8139</issn><issn publication-format="electronic">2658-655X</issn><publisher><publisher-name xml:lang="en">The Russian Academy of Sciences</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">687414</article-id><article-id pub-id-type="doi">10.31857/S0869813925060083</article-id><article-id pub-id-type="edn">TEQXKS</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>EXPERIMENTAL ARTICLES</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ЭКСПЕРИМЕНТАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">The Role of GABA Receptors in Seizure Development When Breathing Hyperbaric Oxygen</article-title><trans-title-group xml:lang="ru"><trans-title>Роль ГАМК-рецепторов в развитии судорог, индуцированных гипербарическим кислородом</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Alekseeva</surname><given-names>O. S.</given-names></name><name xml:lang="ru"><surname>Алексеева</surname><given-names>О. С.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>osa72@inbox.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Platonova</surname><given-names>T. F.</given-names></name><name xml:lang="ru"><surname>Платонова</surname><given-names>Т. Ф.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>osa72@inbox.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Demchenko</surname><given-names>I. T.</given-names></name><name xml:lang="ru"><surname>Демченко</surname><given-names>И. Т.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>osa72@inbox.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Sechenov Institute of Evolutionary Physiology and Biochemistry of the Russian Academy of Sciences</institution></aff><aff><institution xml:lang="ru">Институт эволюционной физиологии и биохимии им. И.М. Сеченова Российской академии наук</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2025-06-15" publication-format="electronic"><day>15</day><month>06</month><year>2025</year></pub-date><volume>111</volume><issue>6</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>944</fpage><lpage>956</lpage><history><date date-type="received" iso-8601-date="2025-07-13"><day>13</day><month>07</month><year>2025</year></date><date date-type="accepted" iso-8601-date="2025-07-13"><day>13</day><month>07</month><year>2025</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2025, Russian Academy of Sciences</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2025, Российская академия наук</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="en">Russian Academy of Sciences</copyright-holder><copyright-holder xml:lang="ru">Российская академия наук</copyright-holder></permissions><self-uri xlink:href="https://journals.eco-vector.com/0869-8139/article/view/687414">https://journals.eco-vector.com/0869-8139/article/view/687414</self-uri><abstract xml:lang="en"><p>The use of hyperbaric oxygen (HBO<sub>2</sub>) in medicine and in underwater diving is associated with the risk of its toxic (convulsant) effect on the central nervous system, the pathophysiological mechanisms of which have not been sufficiently studied. A common hypothesis about the mechanism of HBO<sub>2</sub>-induced convulsions is the idea that extreme hyperoxia suppresses GABAergic function with subsequent increase in CNS excitation, leading to convulsions. The deficit of GABAergic function in HBO<sub>2</sub> is due to a decrease in the synthesis of the mediator, while the involvement of other components of inhibitory neurotransmission, in particular, GABA receptors, remains unclear. The aim of this work was to study the involvement of GABA receptors in the development of hyperbaric oxygen convulsions. In the course of the work, motor convulsions in HBO<sub>2</sub> were assessed in rats that were injected with GABA receptor agonists: muscimol or baclofen into the lateral ventricle of the brain before hyperoxic exposure. The affinity of GABA receptors to these drugs was also assessed against the background of an increased level of cerebral GABA caused by intraventricular administration of nipecotic acid. New data from the studies are: (a) activation of GABA-A receptors with muscimol delayed the onset of seizures in HBO<sub>2</sub>, (b) the GABA-B receptor agonist baclofen weakened the development of hyperbaric oxygen seizures, but its anticonvulsant effect was reliably lower than that of muscimol, (c) the anticonvulsant efficacy of muscimol and baclofen was preserved with an increase in extracellular GABA caused by inhibition of GABA transporters with nipecotic acid. The affinity of GABA-A and GABA-B receptors to the inhibitory neurotransmitter did not change under conditions of hyperbaric hyperoxia.</p></abstract><trans-abstract xml:lang="ru"><p>Использование гипербарического кислорода (ГБО<sub>2</sub>) в медицине и при подводных погружениях сопряжено с риском его токсического (судорожного) действия на ЦНС, патофизиологические механизмы которого изучены недостаточно. Распространенной гипотезой о механизме ГБО<sub>2</sub>-вызываемых судорог является представление о том, что экстремальная гипероксия подавляет ГАМК-ергическую функцию с последующим усилением возбуждения ЦНС, приводящего к судорогам. Дефицит ГАМК-ергической функции в ГБО<sub>2</sub> обусловлен снижением синтеза медиатора, тогда как вовлечение других компонентов тормозной нейротрансмиссии, в частности рецепторов ГАМК, остается неясным. Целью настоящей работы являлось изучение причастности ГАМК-рецепторов к развитию гипербарических кислородных судорог. При выполнении работы оценивались моторные судороги в ГБО<sub>2</sub> у крыс, которым перед гипероксической экспозицией в боковой желудочек головного мозга вводили агонисты ГАМК-рецепторов: мусцимол или баклофен. Аффинность рецепторов ГАМК к этим препаратам оценивалась также на фоне повышенного уровня мозговой ГАМК, вызываемого внутрижелудочковым введением нипекотовой кислоты. Новыми данными выполненных исследований являются: 1) активация ГАМК-А-рецепторов с помощью мусцимола задерживала появление судорог в ГБО<sub>2</sub>; 2) агонист ГАМК-В-рецепторов – баклофен, ослаблял развитие гипербарических кислородных судорог, но его противосудорожный эффект был достоверно ниже, чем у мусцимола; 3) противосудорожная эффективность мусцимола и баклофена сохранялась при повышении внеклеточного ГАМК, вызываемого ингибированием ГАМК-транспортеров с помощью нипекотовой кислоты. Аффинность ГАМК-А- и ГАМК-В-рецепторов к тормозному нейромедиатору не изменялась в условиях гипербарической гипероксии.</p></trans-abstract><kwd-group xml:lang="en"><kwd>hyperbaric oxygen</kwd><kwd>seizures</kwd><kwd>gamma-aminobutyric acid</kwd><kwd>GABA receptors</kwd><kwd>baclofen</kwd><kwd>muscimol</kwd><kwd>nipecotic acid</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>гипербарический кислород</kwd><kwd>судороги</kwd><kwd>гамма-аминомасляная кислота</kwd><kwd>ГАМК-рецепторы</kwd><kwd>баклофен</kwd><kwd>мусцимол</kwd><kwd>нипекотовая кислота</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution xml:lang="ru">Институт эволюционной физиологии и биохимии им. И.М. Сеченова РАН</institution></institution-wrap><institution-wrap><institution xml:lang="en">Sechenov Institute of Evolutionary Physiology and Biochemistry of the Russian Academy of Sciences</institution></institution-wrap></funding-source></award-group></funding-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Dean JB, Mulkey DK, Garcia AJ, Putnam RW, Henderson RA (2003) Neuronal sensitivity to hyperoxia, hypercapnia, and inert gases at hyperbaric pressures. J Appl Physiol (1985) 95(3): 883–909. https://doi.org/10.1152/japplphysiol.00920.2002</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>D'Agostino DP, Putnam RW, Dean JB (2007) Superoxide (*O2-) production in CA1 neurons of rat hippocampal slices exposed to graded levels of oxygen. J Neurophysiol 98(2): 1030–1041. https://doi.org/10.1152/jn.01003.2006</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Demchenko IT, Boso AE, Whorton AR, Piantadosi CA (2001) Nitric oxide production is enhanced in rat brain before oxygen-induced convulsions. Brain Res 917(2): 253–261. https://doi.org/10.1016/s0006-8993 (01)03057-8</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Zhang S, Takeda Y, Hagioka S, Takata K, Aoe H, Nakatsuka H, Yokoyama M, Morita K (2005) Measurement of GABA and glutamate in vivo levels with high sensitivity and frequency. Brain Res Brain Res Protoc 14(2): 61–66. https://doi.org/10.1016/j.brainresprot.2004.03.005</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Кричевская АА, Шугалей ВС, Щербина ЛА, Ермоленко ГГ (1974) Содержание γ-аминомасляной кислоты и активность глютаматдекарбоксилазы в мозге крыс при гипербарической оксигенации и защитном действии мочевины. Вопр мед хим 20(3): 294–298. [Krichevskaya AA, Shugaley VS, Shcherbina LA, Ermolenko GG (1974) The content of γ-aminobutyric acid and the activity of glutamate decarboxylase in the brain of rats under hyperbaric oxygen and the protective action of urea. Vopr Med Chem 20(3): 294–298. (In Russ)].</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Щербакова ГВ (1962) Активность глютаматдекарбоксилазы и содержание γ-аминомасляной кислоты в мозге крыс при разных функциональных состояниях, вызванных повышенным давлением кислорода. Докл АН СССР 146(5): 1213–1215. [Shcherbakova GV (1962) Glutamate decarboxylase activity and γ-aminobutyric acid content in rat brain at different functional states caused by high oxygen pressure. Dokl AN USSR 146(5): 1213–1215. (In Russ)].</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Mialon P, Gibey R, Bigot JC, Barthelemy L (1992) Changes in striatal and cortical amino acid and ammonia levels of rat brain after one hyperbaric oxygen-induced seizures. Aviat Space Environ Med 63(4): 287–291.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Singh AK, Banister EW (1978) Effect of 6-hydroxydopamine on brain and blood catecholamine, ammonia, and amino acid metabolism in rats subjected to high pressure oxygen induced convulsions. Can J Physiol Pharmacol 56(2): 334–336. https://doi.org/10.1139/y78-051</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Gasier HG, Demchenko IT, Tatro LG, Piantadosi CA (2017) S-nitrosylation of GAD65 is implicated in decreased GAD activity and oxygen-induced seizures. Neurosci Lett 653: 283–287. https://doi.org/10.1016/j.neulet.2017.05.067</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Beltrán González AN, López Pazos MI, Calvo DJ (2020) Reactive Oxygen Species in the Regulation of the GABA Mediated Inhibitory Neurotransmission. Neuroscience 15(439): 137–145. https://doi.org/10.1016/j.neuroscience.2019.05.064</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Paxinos G, Watson C (2005) The Rat Brain in Stereotaxic coordinates. Boston. MA. Elsevier.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Moskvin AN, Platonova TP, Zhilyaev SY, Alekseeva OS, Nikitina ER, Demchenko IT (2020) Blockade Of γ-Aminobutyric Acid Transporters in Brain Synapses Protects Against Hyperbaric Oxygen-Induced Convulsions. Neurosci Behav Physiol 50: 505–510. https://doi.org/10.1007/s11055-020-00930-1</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Gernert M, Löscher W (2001) Lack of robust anticonvulsant effects of muscimol microinfusions in the anterior substantia nigra of kindled rats. Eur J Pharm 432: 35–41. https://doi.org/10.1016/S0014-2999(01)01458-3</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Mares P, Lindovský J, Slamberová R, Kubová H (2007) Effects of a GABA-B receptor agonist baclofen on cortical epileptic afterdischarges in rats. Epileptic Disord 1: S44–S51. https://doi.org/10.1684/epd.2007.0151</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Racine RJ (1972) Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephal Clin Neurophysiol 32 (3): 281–294. https://doi.org/10.1016/0013-4694(72)90177-0</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Зальцман ГЛ (1968) Стадии развития кислородной эпилепсии и функциональное состояние нервной системы. В кн: Гипербарические эпилепсия и наркоз. ГЛ Зальцман (ред) Л. Наука. [GL Zaltsman (1968) Stages of formation of oxygen epilepsy and the functional state of the centres of the nervous system. In: Hyperbaric epilepsy and narcosis. Zaltsman GL (ed) Leningrad. Nauka. (In Russ)].</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Demchenko IT, Piantadosi CA (2006) Nitric oxide amplifies the excitatory to inhibitory neurotransmitter imbalance accelerating oxygen seizures. Undersea Hyperb Med 33(3): 169–174.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Demchenko IT, Suliman HB, Zhilyaey SY, Alekseeva OS, Platonova TF, Makowski MS, Piantadosi CA, Gasier HG (2023) GAT inhibition preserves cerebral blood flow and reduces oxidant damage to mitochondria in rodents exposed to extreme hyperbaric oxygen. Front Mol Neurosci 15: 1062410. https://doi.org/10.3389/fnmol.2022.1062410</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Bean JW, Zee D, Thom B (1966) Pulmonary changes with convulsions induced by drugs and oxygen at high pressure. J Appl Physiol 21(3): 865–872. https://doi.org/10.1152/jappl.1966.21.3.865</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Fattore L, Cossu G, Martellotta MC, Deiana S, Fratta W (2001) Baclofen antagonises intravenous self-administration of gamma-hydroxybutyric acid in mice. Neuroreport 12(10): 2243–2246. https://doi.org/10.1097/00001756-200107200-00039</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Fattore L, Cossu G, Martellotta MC, Fratta W (2002) Baclofen antagonizes intravenous self-administration of nicotine in mice and rats. Alcohol Alcohol 37(5): 495–498. https://doi.org/10.1093/alcalc/37.5.495</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Spano MS, Fattore L, Fratta W, Fadda P (2007) The GABAB receptor agonist baclofen prevents heroin-induced reinstatement of heroin-seeking behavior in rats. Neuropharmacology 52(7): 1555–1562. https://doi.org/10.1016/j.neuropharm.2007.02.012</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Gorsane MA, Kebir O, Hache G, Blecha L, Aubin HJ, Reynaud M, Benyamina A (2012) Is baclofen a revolutionary medication in alcohol addiction management? Review and recent updates. Subst Abus 33(4): 336–349. https://doi.org/10.1080/08897077.2012.663326</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Romanova OL, Chauhan M, Blagonravov ML, Kislov MA, Ershov AV, Krupin KN (2022) Baclofen (fun drug) and ethanol combined poisoning in humans: A histopathology and morphometry model. J Forensic Leg Med 90: 102373. https://doi.org/10.1016/j.jflm.2022.102373</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Shaye H, Stauch B, Gati C, Cherezov V (2021) Molecular mechanisms of metabotropic GABAB receptor function. Sci Adv 7(22): 1–15. https://doi.org/10.1126/sciadv.abg3362</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Gassmann M, Bettler B (2012) Regulation of neuronal GABA(B) receptor functions by subunit composition. Nat Rev Neurosci 13(6): 380–394. https://doi.org/10.1038/nrn3249</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Brown JW, Moeller A, Schmidt M, Turner SC, Nimmrich V, Ma J, Rueter LE, van der Kam E, Zhang M (2016) Anticonvulsant effects of structurally diverse GABA(B) positive allosteric modulators in the DBA/2J audiogenic seizure test: Comparison to baclofen and utility as a pharmacodynamic screening model. Neuropharmacology 101: 358–369. https://doi.org/10.1016/j.neuropharm.2015.10.009</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Collins RC (1980) Anticonvulsant effects of muscimol. Neurology 30(6): 575–581. https://doi.org/10.1212/wnl.30.6.575</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Sawamura А, Hashizume K, Yoshida K, Tanaka T (2001) Kainic acid-induced substantia nigra seizure in rats: Вehavior, EEG and metabolism. Brain Res 911(1): 89–95. https://doi.org/10.1016/s0006-8993(01)02732-9</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Enna SJ, Collins JF, Snyder SH (1977) Stereospecificity and structure-activity requirements of GABA receptor binding in rat brain. Brain Res 124(1): 185–190. https://doi.org/ 10.1016/0006-8993(77)90878-2</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Martin JH (1991) Autoradiographic estimation of the extent of reversible inactivation produced by microinjection of lidocaine and muscimol in the rat. Neurosci Lett 127(2): 160–164. https://doi.org/10.1016/0304-3940(91)90784-q</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Kubota K (1996) Motor cortical muscimol injection disrupts forelimb movement in freely moving monkeys. Neuroreport 7(14): 2379–2384. https://doi.org/10.1097/00001756-199610020-00020</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Hosford DA, Wang Y, Cao Z (1997) Differential effects mediated by GABAA receptors in thalamic nuclei in lh/lh model of absence seizures. Epilepsy Res 27(1): 55–65. https://doi.org/ 10.1016/s0920-1211(97)01023-1</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Shehab S, Simkins M, Dean P, Redgrave P (1996) Regional distribution of the anticonvulsant and behavioural effects of muscimol injected into the substantia nigra of rats. Eur J Neurosci 8(4): 749–757. https://doi.org/10.1111/j.1460-9568.1996.tb01260.x</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>Baraldi M, Grandison L, Guidotti A (1979) Distribution and metabolism of muscimol in the brain and other tissues of the rat. Neuropharmacology 18(1): 57–62. https://doi.org/10.1016/0028-3908(79)90009-1</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>Singh K, Kumar P, Bhatia R, Mehta V, Kumar B, Akhtar MJ (2022) Nipecotic acid as potential lead molecule for the development of GABA uptake inhibitors; structural insights and design strategies. Eur J Med Chem 234(15): 114269. https://doi.org/10.1016/j.ejmech.2022.114269</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>Wood JD, Watson WJ (1962) Protective action of gamma-aminobutyric acid against oxygen toxicity. Nature 195: 296.</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>Alekseeva OS, Gerda BA, Zhilyaeva AS, Demchenko IT (2023) Anticonvulsant Efficacy of Inhibition of Synaptic and Extrasynaptic GABA-Transporters in the Prevention of Hyperbaric Oxygen Seizures. J Evol Biochem Phys 59: 709–718. https://doi.org/10.1134/S0022093023030055</mixed-citation></ref></ref-list></back></article>
